UNITED STATES ANTIMONY CORP - Quarter Report: 2012 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
þ
|
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended June 30, 2012
o
|
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period __________ to __________
Commission file number 001-08675
UNITED STATES ANTIMONY CORPORATION
(Exact name of registrant as specified in its charter)
Montana
|
81-0305822
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
P.O. Box 643, Thompson Falls, Montana
|
59873
|
|
(Address of principal executive offices)
|
(Zip code)
|
Registrant’s telephone number, including area code: (406) 827-3523
Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
YES o No o
Indicate by check mark whether the registrant is a shell company as defined by Rule 12b-2 of the Exchange Act.
YES o No þ
At August 10, 2012, the registrant had outstanding 61,803,109 shares of par value $0.01 common stock.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
|
o |
Accelerated filer
|
þ |
Non-accelerated filer
|
o |
Smaller reporting company
|
o |
(Do not check if a smaller reporting company)
|
UNITED STATES ANTIMONY CORPORATION
QUARTERLY REPORT ON FORM 10-Q
FOR THE PERIOD
ENDED JUNE 30, 2012
TABLE OF CONTENTS
Page | ||||
PART I – FINANCIAL INFORMATION
|
||||
Item 1: Financial Statements (unaudited)
|
1-8 | |||
Item 2: Management’s Discussion and Analysis of Results of Operations and Financial Condition
|
9-10 | |||
Item 3: Quantitative and Qualitative Disclosure about Market Risk
|
11 | |||
Item 4: Controls and Procedures
|
11 | |||
PART II – OTHER INFORMATION
|
||||
Item 1: Legal Proceedings
|
12 | |||
Item 2: Unregistered Sales of Equity Securities and Use of Proceeds
|
12 | |||
Item 3: Defaults upon Senior Securities
|
12 | |||
Item 4: Mine Safety Disclosures
|
13 | |||
Item 5: Other Information
|
13 | |||
Item 6: Exhibits and Reports on Form 8-K
|
13 | |||
SIGNATURE
|
14 | |||
CERTIFICATIONS
|
[The balance of this page has been intentionally left blank.]
PART I-FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
United States Antimony Corporation and Subsidiaries
Consolidated Balance Sheets
(Unaudited)
June 30, 2012
|
||||||||
December 31, 2011
|
||||||||
ASSETS
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$ | 3,444,003 | $ | 5,427 | ||||
Certificates of deposit (Note 4)
|
242,800 | |||||||
Accounts receivable, less allowance for doubtful accounts of $4,031 and $7,600, respectively
|
456,508 | 1,291,975 | ||||||
Inventories
|
1,077,271 | 1,066,813 | ||||||
Other current assets
|
57,660 | 56,208 | ||||||
Deferred tax asset
|
470,869 | 396,558 | ||||||
Total current assets
|
5,749,111 | 2,816,981 | ||||||
Properties, plants and equipment, net
|
7,484,436 | 6,047,004 | ||||||
Restricted cash for reclamation bonds
|
74,777 | 74,777 | ||||||
Other assets
|
128,686 | 54,766 | ||||||
Total assets
|
$ | 13,437,010 | $ | 8,993,528 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
Current liabilities:
|
||||||||
Checks issued and payable
|
$ | - | $ | 113,908 | ||||
Deferred revenue
|
- | 43,760 | ||||||
Accounts payable
|
829,329 | 994,940 | ||||||
Accrued payroll, taxes and interest
|
98,409 | 141,928 | ||||||
Other accrued liabilities
|
63,696 | 119,292 | ||||||
Payables to related parties
|
10,434 | 331,978 | ||||||
Long-term debt, current
|
258,988 | 79,631 | ||||||
Total current liabilities
|
1,260,856 | 1,825,437 | ||||||
Long-term debt, noncurrent
|
134,503 | 158,218 | ||||||
Asset retirement and accrued reclamation costs
|
245,520 | 241,500 | ||||||
Total liabilities
|
1,640,879 | 2,225,155 | ||||||
Commitments and contingencies (Note 4)
|
||||||||
Stockholders' equity:
|
||||||||
Preferred stock $0.01 par value, 10,000,000 shares authorized:
|
||||||||
Series A: no shares issued and outstanding
|
- | - | ||||||
Series B: 750,000 shares issued and outstanding
|
||||||||
(liquidation preference $877,500)
|
7,500 | 7,500 | ||||||
Series C: 177,904 shares issued and outstanding
|
||||||||
(liquidation preference $97,847)
|
1,779 | 1,779 | ||||||
Series D: 1,751,005 shares issued and outstanding
|
||||||||
(liquidation preference and cumulative dividends of $4,714,433)
|
17,509 | 17,509 | ||||||
Common stock, $0.01 par vaue, 90,000,000 shares authorized;
|
||||||||
61,786,822 and 59,349,300 shares issued and outstanding, respectively
|
617,868 | 593,492 | ||||||
Additional paid-in capital
|
30,750,974 | 25,635,129 | ||||||
Accumulated deficit
|
(19,599,499 | ) | (19,487,036 | ) | ||||
Total stockholders' equity
|
11,796,131 | 6,768,373 | ||||||
Total liabilities and stockholders' equity
|
$ | 13,437,010 | $ | 8,993,528 |
The accompanying notes are an integral part of the consolidated financial statements.
1
Consolidated Statements of Operations (Unaudited)
|
For the three months ended
|
For the six months ended
|
|||||||||||||||
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
REVENUES
|
$ | 3,498,301 | $ | 3,050,002 | $ | 6,551,855 | $ | 5,888,041 | ||||||||
COST OF REVENUES
|
3,209,381 | 2,805,524 | 6,142,206 | 5,364,696 | ||||||||||||
GROSS PROFIT
|
288,920 | 244,478 | 409,649 | 523,345 | ||||||||||||
OPERATING EXPENSES:
|
||||||||||||||||
General and administrative
|
228,411 | 89,967 | 415,984 | 170,316 | ||||||||||||
Professional fees
|
34,337 | 30,888 | 132,644 | 125,840 | ||||||||||||
TOTAL OPERATING EXPENSES
|
262,748 | 120,855 | 548,628 | 296,156 | ||||||||||||
INCOME (LOSS) FROM OPERATIONS
|
26,172 | 123,623 | (138,979 | ) | 227,189 | |||||||||||
OTHER INCOME (EXPENSE):
|
||||||||||||||||
Interest income
|
1,493 | 1,526 | 3,549 | 2,442 | ||||||||||||
Factoring expense
|
(23,895 | ) | (38,721 | ) | (51,344 | ) | (73,414 | ) | ||||||||
TOTAL OTHER (EXPENSE)
|
(22,402 | ) | (37,195 | ) | (47,795 | ) | (70,972 | ) | ||||||||
INCOME (LOSS) BEFORE INCOME TAXES
|
3,770 | 86,428 | (186,774 | ) | 156,217 | |||||||||||
INCOME TAX (EXPENSE) BENEFIT
|
- | - | 74,311 | (24,426 | ) | |||||||||||
NET INCOME (LOSS)
|
$ | 3,770 | $ | 86,428 | $ | (112,463 | ) | $ | 131,791 | |||||||
Net income (loss) per share of common stock:
|
||||||||||||||||
Basic
|
$ |
Nil
|
$ |
Nil
|
$ |
Nil
|
$ |
Nil
|
||||||||
Diluted
|
$ |
Nil
|
$ |
Nil
|
$ |
Nil
|
$ |
Nil
|
||||||||
Weighted average shares outstanding:
|
||||||||||||||||
Basic
|
61,786,822 | 59,150,784 | 61,786,822 | 58,157,638 | ||||||||||||
Diluted
|
62,427,710 | 59,662,620 | 61,786,822 | 58,618,325 |
The accompanying notes are an integral part of the consolidated financial statements.
2
United States Antimony Corporation and Subsidiaries
|
|||
Consolidated Statements of Cash Flows (Unaudited)
|
For the six months ended
|
||||||||
June 30, 2012
|
June 30, 2011
|
|||||||
Cash Flows From Operating Activities:
|
||||||||
Net income (loss)
|
$ | (112,463 | ) | $ | 131,791 | |||
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
|
||||||||
Depreciation and amortization expense
|
217,385 | 192,503 | ||||||
Accretion of asset retirement obligation
|
4,020 | |||||||
Common stock issued to directors for services
|
176,191 | - | ||||||
Deferred income tax expense (benefit)
|
(74,311 | ) | 21,926 | |||||
Change in:
|
||||||||
Accounts receivable, net
|
835,467 | (349,421 | ) | |||||
Inventories
|
(10,458 | ) | (621,558 | ) | ||||
Other current assets
|
250,736 | (23,770 | ) | |||||
Other assets
|
(73,920 | ) | (5,183 | ) | ||||
Accounts payable
|
(165,611 | ) | 428,132 | |||||
Accrued payroll, taxes and interest
|
(43,519 | ) | 12,839 | |||||
Other accrued liabilities
|
(55,596 | ) | (44,330 | ) | ||||
Deferred revenue
|
(43,760 | ) | - | |||||
Payables to related parties
|
(321,544 | ) | 24,203 | |||||
Net cash provided (used) by operating activities
|
582,617 | (232,868 | ) | |||||
Cash Flows From Investing Activities:
|
||||||||
Purchase of certificates of deposit
|
(242,800 | ) | - | |||||
Purchase of properties, plants and equipment
|
(1,370,877 | ) | (1,037,912 | ) | ||||
Net cash used by investing activities
|
(1,613,677 | ) | (1,037,912 | ) | ||||
Cash Flows From Financing Activities:
|
||||||||
Proceeds from sale of common stock, net of offering costs
|
4,711,842 | 1,163,248 | ||||||
Principal payments on long-term debt
|
(128,298 | ) | (86,958 | ) | ||||
Payments received on stock subscription agreements
|
- | 59,907 | ||||||
Change in checks issued and payable
|
(113,908 | ) | - | |||||
Net cash provided by financing activities
|
4,469,636 | 1,136,197 | ||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
3,438,576 | (134,583 | ) | |||||
Cash and cash equivalents at beginning of period
|
5,427 | 448,861 | ||||||
Cash and cash equivalents at end of period
|
$ | 3,444,003 | $ | 314,278 | ||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
||||||||
Noncash investing and financing activities:
|
||||||||
Properties, plants and equipment acquired with long-term debt
|
$ | 283,940 | $ | 229,100 | ||||
Properties, plants and equipment acquired with accounts payable
|
- | $ | 89,654 | |||||
Common stock issued for prepaid directors fees
|
$ | 358,800 | - |
The accompanying notes are an integral part of the consolidated financial statements.
3
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
1. Basis of Presentation:
The unaudited consolidated financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, as well as the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of the Company’s management, all adjustments (consisting of only normal recurring accruals) considered necessary for a fair presentation of the interim financial statements have been included. Operating results for the three and six month periods ended June 30, 2012 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2012.
Certain consolidated financial statement amounts for the three and six month periods ended June 30, 2011 have been reclassified to conform to the 2012 presentation. These reclassifications had no effect on the net income or accumulated deficit as previously reported.
Management estimates their effective tax rate at 39% for the current year.
For further information refer to the financial statements and footnotes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.
During the six months ended June 30, 2012 and 2011, the Company incurred interest expense of $23,600 and $5,470, respectively, all of which has been capitalized as part of the cost of constructing the Puerto Blanco Mill in Mexico.
2. Income (Loss) Per Common Share:
Basic earnings per share is calculated by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share is calculated based on the weighted average number of common shares outstanding during the period plus the effect of potentially dilutive common stock equivalents, including warrants to purchase the Company's common stock and convertible preferred stock. Management has determined that the calculation of diluted earnings per share for the six month period ending June 30, 2012, is not applicable since any additions to outstanding shares related to common stock purchase warrants would be anti-dilutive.
As of June 30, 2012 and 2011, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive are as follows:
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
Warrants
|
1,248,779 | 88,164 | 1,889,667 | 139,313 | ||||||||||||
Convertible preferred stock
|
1,751,005
|
1,751,005
|
1,751,005
|
1,751,005
|
||||||||||||
Total possible dilution
|
2,999,784
|
1,839,169
|
3,640,672
|
1,890,318
|
3. Inventories
June 30, 2012
|
December 31, 2011
|
|||||||
Antimony Metal
|
11,760 | 152,026 | ||||||
Antimony Oxide
|
186,210 | 180,404 | ||||||
Antimony Ore
|
784,876 | 644,113 | ||||||
Total antimony
|
982,846 | 976,543 | ||||||
Zeolite
|
94,425 | 90,270 | ||||||
$ | 1,077,271 | $ | 1,066,813 |
4
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
4. Commitments and Contingencies:
In 2005, a subsidiary of the Company signed an option agreement that gives it the exclusive right to explore and develop the San Miguel I and San Miguel II concessions for an annual payment of $50,000, and an option to purchase payment of $100,000 annually. Total payments will not exceed $1,430,344, reduced by taxes paid. During the six months ended June 30, 2012 and the year ended December 31, 2011, $0 and $186,956 respectively, was paid and capitalized as mineral rights in accordance with the Company’s accounting policies.
From time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. The Company has accrued $14,263 in other accrued liabilities as of June 30, 2012, related to such assessments.
During the six months ended June 30, 2012, the Company negotiated a new credit facility increasing the Company’s lines of credit by $202,000. As part of this agreement, we have pledged two $101,000 certificates of deposit as collateral. The increased loan facility allows us access to borrowings at an interest rate of 3.15% for the portion of the credit line used. At June 30, 2012, we did not have any outstanding line of credit debt.
5. Long – Term Debt
Long-term debt at June 30, 2012 and December 31, 2011 is as follows:
2012
|
2011
|
|||||||
Note payable to De Lage Landen financial Services, bearing interest
|
||||||||
at 5.3%; payable in monthly installments of $549; maturing
|
||||||||
March 2016; collateralized by equipment.
|
$ | 22,361 | $ | - | ||||
Note payable to Western States Equipment Co., bearing interest
|
||||||||
at 6.15%; payable in monthly installments of $2,032; maturing
|
||||||||
June 2015; collateralized by equipment.
|
66,668 | 77,040 | ||||||
Note payable to CNH Capital America, LLC, bearing interest
|
||||||||
at 4.5%; payable in monthly installments of $505; maturing
|
||||||||
June 2013; collateralized by equipment.
|
5,904 | 8,648 | ||||||
Note payable to GE Capital, bearing interest at 2.25%; payable in
|
||||||||
monthly installments of $359; maturing July 2013; collateralized by
|
||||||||
equipment.
|
4,955 | 6,531 | ||||||
Note payable to Robert and Phyllis Rice, bearing interest
|
||||||||
at 1%; payable in monthly installments of $2,000; maturing
|
||||||||
March 2015; collateralized by equipment.
|
65,206 | 80,882 | ||||||
Note payable to De Lage Landen Financial Services
|
||||||||
at 5.2%; payable in monthly installments of $709; maturing
|
||||||||
July 2014; collateralized by equipment.
|
16,104 | 19,229 | ||||||
Note payable to Catepillar Finance, bearing interest
|
||||||||
at 6.15%; payable in monthly installments of $766; maturing
|
||||||||
August 2014; collateralized by equipment.
|
18,597 | 21,990 | ||||||
Note payable to De Lage Landen Financial Services
|
||||||||
at 5.2%; payable in monthly installments of $697; maturing
|
||||||||
January 2015; collateralized by equipment.
|
20,202 | 23,529 | ||||||
Note payable for Corral Blanco land, bearing interest
|
||||||||
at 6%; payable in three installments; maturing
|
||||||||
May 1, 2013; collateralized by land.
|
173,494 | |||||||
Total debt
|
393,491 | 237,849 | ||||||
Less current portion
|
(258,988 | ) | (79,631 | ) | ||||
Noncurrent portion
|
$ | 134,503 | $ | 158,218 |
5
PART I - FINANCIAL INFORMATION, CONTINUED:
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
6. Concentrations of Risk
During the six months ended June 30, 2012, approximately 86% of the Company's antimony revenues were generated by sales to three customers. Loss of any of the Company’s key customers could adversely affect its business.
7. Related Party Transactions
During the first three and six months of 2012 and 2011, the Company paid $6,655 and $22,026 in 2012, and $45,452 and $79,409 in 2011, respectively, to directors of the Company for services provided in permitting and other construction related activities at Mexican mill sites.
During the first three and six months of 2012 and 2011, the Company paid $16,875 and $38,715 in 2012, and $28,679 and $44,582 in 2011, respectively, to John Lawrence, our president and Chief Executive Officer, as reimbursement for equipment used by the Company.
8. Stockholder’s Equity
Issuance of Common Stock for Cash
During the six months ending June 30, 2012, the Company sold an aggregate of 2,056,334 shares of unregistered common stock to existing stockholders and other parties for $4,702,303. In connection with the sales of the Company’s common stock, 1,028,167 warrants to purchase shares of the Company’s common stock at $2.50 per share, and 1,425,982 warrants at $3.50 per share, were issued. Expenses of $414,661 connected to the issuance of the unregistered shares were deducted from additional paid in capital. 200,000 shares were issued as an exercise of warrants at $.30 per share for a total of $60,000. Also in the first six months of 2012, 25,265 shares were issued in a cashless exercise of warrants, which resulted in an addition of $263 to capital stock, and a corresponding reduction to additional paid in capital. No share or warrants to purchase shares of the Company’s common stock were issued in the first six months of 2011.
Issuance of Common Stock for Services
At December 31, 2011, the Company declared, but did not issue, 95,835 shares of unregistered common stock to be paid to its directors for services, having a fair value of $230,004, based on the current stock price at the date declared. During the first six months of 2012, the company issued 149,500 shares of unregistered common stock with a fair market value of $358,800 to the Directors as compensation for past and future services. During the first six months of 2012, the Company awarded 39,406 of the remaining 53,665 shares of unregistered common stock to its directors for services, having a fair value of $151,190, based on the current stock price at the date awarded. 6,423 new shares with a fair value of $25,000 were issued to directors who were not board members at December 31, 2011. This expense is classified with general and administrative expense in the consolidated statement of operations.
Common Stock Warrants
The Company's Board of Directors has the authority to issue stock warrants for the purchase of preferred or unregistered common stock to directors and employees of the Company.
6
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
Transactions in common stock warrants are as follows:
Number of
|
Exercise
|
|||||||
Warrants
|
Prices
|
|||||||
Balance, December 31, 2010
|
725,000 | $ | 0.20-$0.75 | |||||
Warrants exercised
|
(125,000 | ) | $ | 0.30-$0.40 | ||||
Balance, December 31, 2011
|
600,000 | $ | 0.30-$0.60 | |||||
Warrants granted
|
1,579,417 | $ | 2.50-$4.50 | |||||
Warrants exercised
|
(52,500 | ) | $ | 2.50 | ||||
Warrants expired
|
(350,000 | ) | $ | 0.30-$0.40 | ||||
Balance, June 30, 2012
|
1,776,917 | $ | 0.20-$4.50 | |||||
The above common stock warrants expire as follows:
|
||||||||
Year Ended December 31:
|
||||||||
2014
|
1,050,000 | |||||||
2015
|
476,917 | |||||||
Thereafter
|
250,000 | |||||||
1,776,917 |
9. Business Segments
The Company has two operating segments, antimony and zeolite. Management reviews and evaluates the operating segments exclusive of interest and factoring expenses. Therefore, interest expense and factoring is not allocated to the segments. Selected information with respect to segments is as follows:
As of
June 30, 2012
|
As of
December 31, 2011
|
|||||||
Properties, plants and equipment, net:
|
||||||||
Antimony
|
||||||||
United States
|
$ | 1,705,370 | $ | 1,657,473 | ||||
Mexico
|
4,125,674 | 2,791,233 | ||||||
Subtotal Antimony
|
5,831,044 | 4,448,706 | ||||||
Zeolite
|
1,653,392 | 1,598,298 | ||||||
Total
|
$ | 7,484,436 | $ | 6,047,004 | ||||
Total Assets:
|
||||||||
Antimony
|
||||||||
United States
|
$ | 6,409,667 | $ | 2,240,836 | ||||
Mexico
|
4,973,792 | 4,291,187 | ||||||
Subtotal Antimony
|
11,383,459 | 6,532,023 | ||||||
Zeolite
|
2,053,551 | 2,461,505 | ||||||
Total
|
$ | 13,437,010 | $ | 8,993,528 |
For the three months ended
|
For the six months ended
|
|||||||||||||||
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
Capital expenditures:
|
||||||||||||||||
Antimony
|
||||||||||||||||
United States
|
$ | 17,850 | $ | 22,067 | $ | 62,618 | $ | 79,289 | ||||||||
Mexico
|
671,987 | 997,867 | 1,434,827 | 1,089,236 | ||||||||||||
Subtotal Antimony
|
689,837 | 1,019,934 | 1,497,445 | 1,168,525 | ||||||||||||
Zeolite
|
116,485 | 188,140 | 157,372 | 188,140 | ||||||||||||
Total
|
$ | 806,322 | $ | 1,208,074 | $ | 1,654,817 | $ | 1,356,665 |
7
United States Antimony Corporation and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued:
For the three months ended
|
For the six months ended
|
|||||||||||||||
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
Revenues:
|
||||||||||||||||
Antimony
|
$ | 2,525,097 | $ | 2,421,903 | $ | 4,699,906 | $ | 4,686,136 | ||||||||
Precious metals
|
205,771 | 157,841 | 385,909 | 339,040 | ||||||||||||
Zeolite
|
767,433 | 470,258 | 1,466,040 | 862,865 | ||||||||||||
Total
|
$ | 3,498,301 | $ | 3,050,002 | $ | 6,551,855 | $ | 5,888,041 |
For the three months ended
|
For the six months ended
|
|||||||||||||||
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
Gross profit:
|
||||||||||||||||
Antimony
|
$ | 191,146 | $ | 246,991 | $ | 264,978 | $ | 528,237 | ||||||||
Zeolite
|
97,774 | (2,513 | ) | 144,671 | (4,892 | ) | ||||||||||
Total
|
$ | 288,920 | $ | 244,478 | $ | 409,649 | $ | 523,345 |
For the three months ended
|
For the six months ended
|
|||||||||||||||
June 30, 2012
|
June 30, 2011
|
June 30, 2012
|
June 30, 2011
|
|||||||||||||
Depreciation and amortization:
|
||||||||||||||||
Antimony
|
$ | 57,553 | $ | 50,039 | $ | 115,106 | $ | 96,866 | ||||||||
Zeolite
|
52,461 | 49,498 | 102,278 | 95,637 | ||||||||||||
Total
|
$ | 110,014 | $ | 99,537 | $ | 217,384 | $ | 192,503 |
8
ITEM 2. Management’s Discussion and Analysis of Results of Operations and Financial Condition
General
This report contains both historical and prospective statements concerning the Company and its operations. Prospective statements (known as "forward-looking statements") may or may not prove true with the passage of time because of future risks and uncertainties. The Company cannot predict what factors might cause actual results to differ materially from those indicated by prospective statements.
For the three and six month periods ended June 30, 2012 compared to the three and six month periods ended June 30, 2011.
Results of Operations by Division
|
||||||||||||||||
2nd Qtr
|
2nd Qtr
|
Six Months
|
Six Months
|
|||||||||||||
Antimony - Combined USA and Mexico
|
2012
|
2011
|
2012
|
2011
|
||||||||||||
Lbs of Antimony Metal USA
|
320,671 | 290,499 | 569,265 | 569,159 | ||||||||||||
Lbs of Antimony Metal Mexico
|
70,259 | 29,663 | 165,617 | 72,364 | ||||||||||||
Total Lbs of Antimony Metal Sold
|
390,930 | 320,162 | 734,882 | 641,523 | ||||||||||||
Sales Price/Lb Metal
|
$ | 6.46 | $ | 7.56 | $ | 6.40 | $ | 7.30 | ||||||||
EBITDA/Lb Metal
|
$ | 0.64 | $ | 0.93 | $ | 0.52 | $ | 0.97 | ||||||||
Operating Income/Lb Metal
|
$ | 0.49 | $ | 0.77 | $ | 0.36 | $ | 0.82 | ||||||||
Gross antimony revenue - net of discount
|
$ | 2,525,097 | $ | 2,421,903 | $ | 4,699,906 | $ | 4,686,136 | ||||||||
Precious metals revenue
|
205,771 | 157,841 | 385,909 | 339,040 | ||||||||||||
Production costs - USA
|
(1,647,645 | ) | (1,922,781 | ) | (3,155,275 | ) | (3,516,347 | ) | ||||||||
Product cost - Mexico
|
(328,110 | ) | (138,526 | ) | (773,433 | ) | (337,940 | ) | ||||||||
Direct sales and freight
|
(139,518 | ) | (65,220 | ) | (213,977 | ) | (143,504 | ) | ||||||||
General and administrative
|
(135,872 | ) | (50,062 | ) | (199,498 | ) | (106,687 | ) | ||||||||
Mexico non-production costs
|
(231,024 | ) | (106,125 | ) | (363,548 | ) | (295,595 | ) | ||||||||
EBITDA
|
248,699 | 297,030 | 380,084 | 625,103 | ||||||||||||
Depreciation & amortization
|
(57,553 | ) | (50,039 | ) | (115,106 | ) | (96,866 | ) | ||||||||
Operating income - antimony
|
$ | 191,146 | $ | 246,991 | $ | 264,978 | $ | 528,237 | ||||||||
Zeolite
|
||||||||||||||||
Tons sold
|
3,251 | 3,133 | 6,717 | 5,843 | ||||||||||||
Sales Price/Ton
|
$ | 236.06 | $ | 150.10 | $ | 218.26 | $ | 147.67 | ||||||||
EBITDA/Ton
|
$ | 236.06 | $ | 150.10 | $ | 218.26 | $ | 147.67 | ||||||||
Operating Income (Loss)/Ton
|
$ | 30.08 | $ | (0.80 | ) | $ | 21.54 | $ | (0.84 | ) | ||||||
Gross zeolite revenue
|
$ | 767,433 | $ | 470,258 | $ | 1,466,040 | $ | 862,865 | ||||||||
Production costs
|
(492,674 | ) | (315,310 | ) | (980,976 | ) | (588,612 | ) | ||||||||
Direct sales and freight
|
(46,442 | ) | (28,980 | ) | (89,718 | ) | (45,090 | ) | ||||||||
Royalties
|
(62,236 | ) | (52,139 | ) | (129,046 | ) | (97,051 | ) | ||||||||
General and administrative
|
(15,846 | ) | (26,844 | ) | (19,351 | ) | (41,367 | ) | ||||||||
EBITDA
|
150,235 | 46,985 | 246,949 | 90,745 | ||||||||||||
Depreciation
|
(52,461 | ) | (49,498 | ) | (102,278 | ) | (95,637 | ) | ||||||||
Operating income (Loss) - zeolite
|
$ | 97,774 | $ | (2,513 | ) | $ | 144,671 | $ | (4,892 | ) | ||||||
Company-wide
|
||||||||||||||||
Gross revenue
|
$ | 3,498,301 | $ | 3,050,002 | $ | 6,551,855 | $ | 5,888,041 | ||||||||
Production costs
|
(2,468,429 | ) | (2,376,617 | ) | (4,909,684 | ) | (4,442,899 | ) | ||||||||
Other operating costs
|
(630,938 | ) | (329,370 | ) | (1,015,138 | ) | (729,294 | ) | ||||||||
EBITDA
|
398,934 | 344,015 | 627,033 | 715,848 | ||||||||||||
Depreciation & amortization
|
(110,014 | ) | (99,537 | ) | (217,384 | ) | (192,503 | ) | ||||||||
Operating income
|
288,920 | 244,478 | 409,649 | 523,345 | ||||||||||||
Net interest
|
1,493 | 1,526 | 3,549 | 2,442 | ||||||||||||
General and administrative costs
|
(132,657 | ) | (89,967 | ) | (211,466 | ) | (170,316 | ) | ||||||||
Board of Directors compensation
|
(95,754 | ) | (204,518 | ) | ||||||||||||
Professional fees
|
(34,337 | ) | (30,888 | ) | (132,644 | ) | (125,840 | ) | ||||||||
Factoring expense
|
(23,895 | ) | (38,721 | ) | (51,344 | ) | (73,414 | ) | ||||||||
Income tax benefit (expense)
|
74,311 | (24,426 | ) | |||||||||||||
Net income (loss)
|
$ | 3,770 | $ | 86,428 | $ | (112,463 | ) | $ | 131,791 |
9
PART I - FINANCIAL INFORMATION, CONTINUED:
ITEM 2. Management’s Discussion and Analysis of Results of Operations and FinancialCondition, continued
The pounds of antimony produced and sold was up for the quarter, but the sales price per pound was down from the prior year. A temporary decrease in the delivery of raw materials from a major supplier in June resulted in decreased results for the quarter, but the deliveries have resumed and are on schedule. The pounds of product (raw material) from Mexico increased for the quarter and the six months, and we should see additional increases in the upcoming quarters. Costs incurred in getting the Mexico plants in operation were substantial in 2012, and will continue during the remainder of the year as production is being ramped up. Conversely, we will have more antimony products from Mexico to sell, and the cost of raw material per pound of antimony produced will decrease as we are able to work more raw materials from Mexico into our production. In addition, we expect to have increased revenue from precious metals as we process more of the raw materials supplied by our Mexico division. We contracted in July 2012 to install a natural gas pipeline for our Mexico smelter operation. Our fuel costs are our second largest expense after raw material in Mexico, and we are expecting the switch from propane to natural gas to decrease our Mexico fuel costs by 75%. The pipeline should be completed in approximately nine to twelve months.
The tons of zeolite sold increased from the comparable periods for 2011, and the sales price per ton was also better than the prior year. We expect this to continue through the remainder of the year.
Our general and administrative costs are significantly higher than the prior year, and management is aggressively seeking ways to bring this cost down.
Financial Condition and Liquidity
|
June 30, 2012
|
December 31, 2011
|
||||||
Current Assets
|
$ | 5,749,111 | $ | 2,816,981 | ||||
Current liabilities
|
(1,260,856 | ) | (1,595,433 | ) | ||||
Net Working Capital
|
$ | 4,488,255 | $ | 1,221,548 | ||||
Cash provided (used) by operations
|
$ | 582,617 | $ | 564,041 | ||||
Cash (used) by investing
|
(1,613,677 | ) | (2,239,441 | ) | ||||
Cash provided (used) by financing:
|
||||||||
Principal paid on long-term debt
|
(128,298 | ) | (124,722 | ) | ||||
Sale of Stock
|
4,711,842 | 1,242,780 | ||||||
Other
|
(113,908 | ) | 113,908 | |||||
Net change in cash
|
$ | 3,438,576 | $ | (443,434 | ) |
Net cash provided by financing activities during the first six months of 2012 and 2011 was $4,469,636 and $1,136,197, respectively, and was primarily generated from the sale of common stock.
Our liquidity (cash) and working capital has improved by approximately $3.5 million from December 31, 2011. This was primarily due to an increase in cash, which is approximately the net cash received from issuing $4.7 million of common stock, and expending $1.4 million for capital improvements and operations. Decreases in our accounts receivable increased our cash position at June 30, 2012, and the primary decreases to cash were for payments of accounts payable, checks issued but not cleared at end of year, and payments on long term debt. We have lines of credit of $202,000 which have not been drawn on at June 30, 2012.
10
PART I - FINANCIAL INFORMATION, CONTINUED:
ITEM 3. Quantitative and Qualitative Disclosure about Market Risk
We sell our antimony products based on a world market price, and we buy a majority of our raw material based on the same market prices. Analysis of our costs indicate that, for the quarter and six months ended June 30, 2012, raw materials were approximately 50% of our cost of goods sold. Most of our production costs are fixed in nature, and could not be decreased readily without decreasing our production. During the quarter and six months ending June 30, 2012, a $2 per pound decrease in our sales price would have likely caused our gross profit to decrease $1 per pound.
ITEM 4. Controls and Procedures
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosure. Our chief financial officer conducted an evaluation of the effectiveness of the Company's disclosure controls and procedures (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as of June 30, 2012.
It was determined that there were material weaknesses affecting our disclosure controls and procedures and, as a result of those weaknesses, our disclosure controls and procedures were not effective as of June 30, 2012. These material weaknesses are as follows:
●
|
The Company lacks proper segregation of duties. As with any company the size of ours, this lack of segregation of duties is due to limited resources. The president authorizes the majority of the expenditures and signs checks.
|
●
|
During its year-end audit, our independent registered accountants discovered material misstatements in our financial statements that required audit adjustments.
|
MANAGEMENT'S REMEDIATION INITIATIVES
We are aware of these material weaknesses and plan to put procedures in place to ensure that independent review of material transactions is performed. In addition, we plan to consult with independent experts when complex transactions are entered into.
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
The Company appointed three independent Director’s to an Audit Committee which has been actively involved in the Company's internal controls over financial reporting through communications with the Company’s management and outside auditors.
11
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During the three month period ended March 31, 2012, the Company sold shares of its restricted common stock directly and through the exercise of outstanding stock purchase warrants as follows: 1,102,500 shares for $2.00 per share ($2,205,000), and 200,000 shares for $.30 per share ($60,000).
During the three month period ended June 30, 2012, the Company sold shares of its restricted common stock directly and through the exercise of outstanding stock purchase warrants as follows: 953,834 shares for $3.00 per share ($2,851,964), and 25,265 shares were issued as a cashless exercise of warrants.
$414,661 was paid for fees in connection with the issuance of the above shares, and was recorded as a reduction of additional paid in capital.
Common stock sold is restricted as defined under Rule 144. In management's opinion, the offer and sale of the securities were made in reliance on exemptions from registration provided by Section 4(2) and Rule 506 of Regulation D of the Securities Act of 1933, as amended and other applicable Federal and state securities laws. Proceeds received on sales of common stock were used for general corporate purposes.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
The registrant has no outstanding senior securities.
12
ITEM 4. MINE SAFETY DISCLOSURES
Pursuant to Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the United States are required to disclose in their periodic reports filed with the SEC information regarding specified health and safety violations, orders and citations, related assessments and legal actions, and mining-related fatalities. During the six month period ended June 30, 2012, the Company had no material specified health and safety violations, orders or citations, related assessments or legal actions, mining-related fatalities, or similar events in relation to the Company’s United States operations requiring disclosure pursuant to Section 1503(a) of the Dodd-Frank Act.
Mine
|
Mine Act §104 Violations (1)
|
Mine Act §104(b) Orders (2)
|
Mine Act §104(d) Citations and Orders (3)
|
Mine Act §(b)(2) Violations (4)
|
Mine Act §107(a) Orders (5)
|
Proposed Assessments from MSHA (In dollars$)
|
Mining Related Fatalities
|
Mine Act §104(e) Notice (yes/no) (6)
|
Pending Legal Action before Federal Mine Saftey and Health Review Commission (yes/no)
|
|||||||||||||||||||||||||||
Bear River Zeolite
|
0 | 0 | 0 | 0 | 0 | $ | 1,126.00 | 0 | No | No |
ITEM 5. OTHER INFORMATION
None
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
Certifications
|
Certifications Pursuant to the Sarbanes-Oxley Act
|
Reports on Form 8-K None
|
|
13
SIGNATURE
Pursuant to the requirements of Section 13 or 15(b) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
UNITED STATES ANTIMONY CORPORATION
(Registrant)
By: | Date: | ||||
John C. Lawrence, Director and President | |||||
(Principal Executive)
|
|||||
By: | Date: | ||||
Daniel L. Parks, Chief Financial Officer
|
14